![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents
Yunlong Cao, Fanchong Jian, Zhiying Zhang, et al.
Cell Reports (2022) Vol. 41, Iss. 12, pp. 111845-111845
Open Access | Times Cited: 86
Yunlong Cao, Fanchong Jian, Zhiying Zhang, et al.
Cell Reports (2022) Vol. 41, Iss. 12, pp. 111845-111845
Open Access | Times Cited: 86
Showing 1-25 of 86 citing articles:
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
Yunlong Cao, Fanchong Jian, Jing Wang, et al.
Nature (2022)
Open Access | Times Cited: 527
Yunlong Cao, Fanchong Jian, Jing Wang, et al.
Nature (2022)
Open Access | Times Cited: 527
ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5
Can Yue, Weiliang Song, Lei Wang, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 3, pp. 278-280
Open Access | Times Cited: 272
Can Yue, Weiliang Song, Lei Wang, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 3, pp. 278-280
Open Access | Times Cited: 272
Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike
Qian Wang, Yicheng Guo, Liyuan Liu, et al.
Nature (2023) Vol. 624, Iss. 7992, pp. 639-644
Open Access | Times Cited: 139
Qian Wang, Yicheng Guo, Liyuan Liu, et al.
Nature (2023) Vol. 624, Iss. 7992, pp. 639-644
Open Access | Times Cited: 139
Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting
Ayijiang Yisimayi, Weiliang Song, Jing Wang, et al.
Nature (2023) Vol. 625, Iss. 7993, pp. 148-156
Open Access | Times Cited: 131
Ayijiang Yisimayi, Weiliang Song, Jing Wang, et al.
Nature (2023) Vol. 625, Iss. 7993, pp. 148-156
Open Access | Times Cited: 131
Antigenicity and infectivity characterisation of SARS-CoV-2 BA.2.86
Sijie Yang, Yuanling Yu, Fanchong Jian, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 11, pp. e457-e459
Open Access | Times Cited: 129
Sijie Yang, Yuanling Yu, Fanchong Jian, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 11, pp. e457-e459
Open Access | Times Cited: 129
Enhanced transmissibility of XBB.1.5 is contributed by both strong ACE2 binding and antibody evasion
Can Yue, Weiliang Song, Lei Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 74
Can Yue, Weiliang Song, Lei Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 74
Fitness effects of mutations to SARS-CoV-2 proteins
Jesse D. Bloom, Richard A. Neher
Virus Evolution (2023) Vol. 9, Iss. 2
Open Access | Times Cited: 67
Jesse D. Bloom, Richard A. Neher
Virus Evolution (2023) Vol. 9, Iss. 2
Open Access | Times Cited: 67
Convergent evolution of SARS-CoV-2 XBB lineages on receptor-binding domain 455–456 synergistically enhances antibody evasion and ACE2 binding
Fanchong Jian, Leilei Feng, Sijie Yang, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 12, pp. e1011868-e1011868
Open Access | Times Cited: 63
Fanchong Jian, Leilei Feng, Sijie Yang, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 12, pp. e1011868-e1011868
Open Access | Times Cited: 63
Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting
Ayijiang Yisimayi, Weiliang Song, Jing Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 43
Ayijiang Yisimayi, Weiliang Song, Jing Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 43
Unsupervised evolution of protein and antibody complexes with a structure-informed language model
Varun R. Shanker, Theodora U. J. Bruun, Brian Hie, et al.
Science (2024) Vol. 385, Iss. 6704, pp. 46-53
Closed Access | Times Cited: 24
Varun R. Shanker, Theodora U. J. Bruun, Brian Hie, et al.
Science (2024) Vol. 385, Iss. 6704, pp. 46-53
Closed Access | Times Cited: 24
Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages
Harold Marcotte, Yunlong Cao, Fanglei Zuo, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 3
Open Access | Times Cited: 17
Harold Marcotte, Yunlong Cao, Fanglei Zuo, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 3
Open Access | Times Cited: 17
Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1
Fanchong Jian, Jing Wang, Ayijiang Yisimayi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 16
Fanchong Jian, Jing Wang, Ayijiang Yisimayi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 16
Evolution of the SARS-CoV-2 Omicron Variants: Genetic Impact on Viral Fitness
Wenhao Liu, Zehong Huang, Jin Xiao, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 184-184
Open Access | Times Cited: 14
Wenhao Liu, Zehong Huang, Jin Xiao, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 184-184
Open Access | Times Cited: 14
Identification of a highly conserved neutralizing epitope within the RBD region of diverse SARS-CoV-2 variants
Yanqun Wang, An Yan, Deyong Song, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Yanqun Wang, An Yan, Deyong Song, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity
Leire de Campos‐Mata, Benjamin Trinité, Andrea Modrego, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Leire de Campos‐Mata, Benjamin Trinité, Andrea Modrego, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Fitness effects of mutations to SARS-CoV-2 proteins
Jesse D. Bloom, Richard A. Neher
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 30
Jesse D. Bloom, Richard A. Neher
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 30
Convergent evolution of SARS-CoV-2 XBB lineages on receptor-binding domain 455-456 synergistically enhances antibody evasion and ACE2 binding
Fanchong Jian, Leilei Feng, Sijie Yang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 22
Fanchong Jian, Leilei Feng, Sijie Yang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 22
An update on the anti-spike monoclonal antibody pipeline for SARS-CoV-2
Daniele Focosi, Massimo Franchini, Arturo Casadevall, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 8, pp. 999-1006
Closed Access | Times Cited: 9
Daniele Focosi, Massimo Franchini, Arturo Casadevall, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 8, pp. 999-1006
Closed Access | Times Cited: 9
Neutralization of SARS-CoV-2 BA.2.86 and JN.1 by CF501 adjuvant-enhanced immune responses targeting the conserved epitopes in ancestral RBD
Zezhong Liu, Jie Zhou, Weijie Wang, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 3, pp. 101445-101445
Open Access | Times Cited: 8
Zezhong Liu, Jie Zhou, Weijie Wang, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 3, pp. 101445-101445
Open Access | Times Cited: 8
COVID-19 therapeutics
Daniele Focosi, Massimo Franchini, Fabrizio Maggi, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 8
Daniele Focosi, Massimo Franchini, Fabrizio Maggi, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 8
Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination
William N. Voss, Michael L. Mallory, Patrick O. Byrne, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 8, pp. 101668-101668
Open Access | Times Cited: 7
William N. Voss, Michael L. Mallory, Patrick O. Byrne, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 8, pp. 101668-101668
Open Access | Times Cited: 7
Robust Neutralization of SARS-CoV-2 Variants Including JN.1 and BA.2.87.1 by Trivalent XBB Vaccine-Induced Antibodies
Xun Wang, Shujun Jiang, Wentai Ma, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
Xun Wang, Shujun Jiang, Wentai Ma, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
Antigenicity assessment of SARS-CoV-2 saltation variant BA.2.87.1
Sijie Yang, Yuanling Yu, Fanchong Jian, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Sijie Yang, Yuanling Yu, Fanchong Jian, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6
A generalized framework to identify SARS-CoV-2 broadly neutralizing antibodies
Fanchong Jian, Anna Z. Wec, Leilei Feng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
Fanchong Jian, Anna Z. Wec, Leilei Feng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
AlphaFold2 Modeling and Molecular Dynamics Simulations of the Conformational Ensembles for the SARS-CoV-2 Spike Omicron JN.1, KP.2 and KP.3 Variants: Mutational Profiling of Binding Energetics Reveals Epistatic Drivers of the ACE2 Affinity and Escape Hotspots of Antibody Resistance
Nishank Raisinghani, Mohammed Alshahrani, Grace Gupta, et al.
Viruses (2024) Vol. 16, Iss. 9, pp. 1458-1458
Open Access | Times Cited: 6
Nishank Raisinghani, Mohammed Alshahrani, Grace Gupta, et al.
Viruses (2024) Vol. 16, Iss. 9, pp. 1458-1458
Open Access | Times Cited: 6